Sun Pharma Shares Jump 5% After $11.75 Billion Organon Acquisition, Marking Biggest Overseas Bet
Sun Pharmaceutical Industries has agreed to buy US drugmaker Organon in an all-cash deal valued at US$ 11.75 billion, in one of the biggest overseas acquisitions ever announced by an Indian company. The deal gives Organon shareholders US$ 14 per share and is expected to close in early 2027,